Menu
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.

Richardson SI, Chung AW, Natarajan H, Mabvakure B, Mkhize NN, Garrett N, Abdool Karim SS, Moore PL, Ackerman ME, Alter G, Morris L.
PLoS Pathogens 2018; 14(4): e1006987. doi: 10.1371/journal.ppat.1006987.

Read publication
Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells.

Mvubu NE, Pillay B, McKinnon LR, Pillay M.
Cytokine 2018; 104:53-64.

Read publication
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.

Gupta RK, Gregson J, Parkin N, Haile-Selassie H, Tanuri A, Andrade Forero L, Kaleebu P, Watera C, Aghokeng A, Mutenda N, Dzangare J, Hone S, Hang ZZ, Garcia J, Garcia Z, Marchorro P, Beteta E, Giron A, Hamers R, Inzaule S, Frenkel LM, Chung MH, de Oliveira T, Pillay D, Naidoo K, Kharsany A, Kugathasan R, Cutino T, Hunt G, Avila Rios S, Doherty M, Jordan MR, Bertagnolio S.
Lancet Infectious Diseases 2018; 18(3):346-355.

Read publication
Mobility and increased risk of HIV acquisition in South Africa: a mixed-method systematic review protocol.

Dzomba A, Govender K, Mashamba-Thompson TP, Tanser F.
Systematic Reviews 2018; 7(1):37. doi: 10.1186/s13643-018-0703-z.

Read publication
Impact of the scale-up of piped water on urogenital schistosomiasis infection in rural South Africa.

Tanser F, Azongo DK, Vandormael A, Bärnighausen T, Appleton C.
eLife. 2018; 7: e33065. doi: 10.7554/eLife.33065.

Read publication
Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection.

Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH.
Journal of the International AIDS Society 2018; 21(2):e25082. doi: 10.1002/jia2.25082.

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.